Donor Spotlight: Initiatives Made Possible by Movember

Thanks to the support all of the Mo Bros and Mo Sistas, we’re excited to announce some new initiatives made possible by your funding achievements.

Of the $42 million raised by 2011 Movember participants, $32.8 million was directed towards PCC projects. Already $3.2 million of this amount has been invested in research and support services, such as Clinician Scientist awards, Pilot Grants and A Survivorship Action Partnership (ASAP). For details on prostate cancer programs run by the Movember foundation and a full breakout of cost, please visit ca.movember.com/about/money/

We plan to have committed an additional $22M to research and survivorship projects in the summer of 2013 through these new initiatives with the remainder of the 2011 Movember revenue fully committed to projects later in the fall subject to the quality of applications received.

Careful strategic planning will continue to ensure that your donor dollars are spent wisely on the most promising projects in Canada, as outlined in our Research Strategic Plan. Examples include the Movember Team Grants and Rising Star in Prostate Cancer Research programs.

These charts show planned expenditures on programs. They are subject to some modification based on PCC Board approval as well as the number and quality of submissions received in each category. Discovery Grants and Rising Star Awards were formerly known as Pilot Grants and Clinician Scientist Awards respectively.


A Survivorship Action Partnership
Other Survivorship Projects
Discovery Grants
Rising Star Awards
Team Grants
Clinical Trial Program
Research Requests for Applications
Health Education Technology
Integrated Supportive Care Service
 







More Information:
Ethics & Accountability
Privacy Policy


Subscribe to our free monthly e-newsletter!

* indicates required

 



PCC Spotlight
New test developed to detect men at high risk of prostate cancer recurrence

Vienna, Austria: A new genetic “signature” to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday). More

CanCertainty for All: Cancer’s Not Fair, But Accessing Treatment Should Be

Toronto, ON – March 10, 2014 – There is no disputing a cancer diagnosis is among the worst news a person or their family could receive. More

$1.8 Million awarded to Movember Rising Stars Supporting Innovators in Prostate Cancer Research

Toronto, ON – February 12, 2014 – Prostate Cancer Canada (PCC) is proud to announce the recipients of its 2014 Movember Rising Star awards in prostate cancer research. More

Support for Those Affected by Prostate Cancer

Toronto, ON - January 28, 2014 – We are pleased to announce a partnership between Prostate Cancer Canada and the Canadian Cancer Society in launching the Prostate Cancer Information Service (PCIS), which provides support to anyone affected by prostate cancer. More


Click here for news archive